Trends in the Outcomes of High-risk Percutaneous Ventricular Assist Device-assisted Percutaneous Coronary Intervention, 2008-2018
Percutaneous ventricular assist devices (pVAD) are frequently utilized in high-risk percutaneous coronary intervention (HR-PCI) to provide hemodynamic support in patients with complex cardiovascular disease and/or multiple comorbidities who are poor candidates for surgical revascularization. Using the National Inpatient Sample we identified pVAD-assisted PCI (excluding intra-aortic balloon pump) in patients without cardiogenic shock from January 2008 to December 2018. We evaluated the trends in patient and procedural characteristics, and complication rates across the 11-year study period.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Alejandro Lemor, Mir B. Basir, Alexander G. Truesdell, Jacqueline E. Tamis-Holland, Mohammad Alqarqaz, Cindy L. Grines, Pedro A. Villablanca, Khaldoon Alaswad, Duane S. Pinto, William O'Neill Source Type: research
More News: Angioplasty | Cardiogenic Shock | Cardiology | Cardiovascular | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention | Study